Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Ex Input:
"The article does not mention costs. The story provides absolute proportions of children who were overweight or obese at 5 or 7 years old. Groups compared included children of those mothers with normal glucose levels, children of those with a diabetes diagnosis who were treated, and children of those with high blood sugar levels who were not treated. Although it’s not entirely clear which group actually received treatment. The study does not mention any harms of treatment for high blood sugar, which could potentially include severe episodes of low blood sugar (if treated with insulin). Would also have been helpful to say more about the lifestyle/nutrition interventions and to note that they have not been found to cause harm, though the effects of materal stress/worry and the costs of blood glucose monitoring are not well studied. The story does not make it clear what type of evidence the findings are based on. For instance, it’s not clear if results are from a randomized trial (the gold standard) or some other study design. An astute reader may be able to infer that this is not a randomized clinical trial from the statement that data were ""analyzed"", but one also doesn’t know if the design was prospective or retrospective, which would add to knowledge about the strength of the study. The fact that we actually don’t know what treatment women actually got is also not clearly discussed. There is no obvious embellishment or mistatement about gestational diabetes. The article provides a brief, but accurate description of what it is. The lead line ""women who develop diabetes during pregnancy"" is somewhat misleading because without clarification of the often transient nature of gestational diabetes, readers could think it means Type II diabetes – women who develop and continue to have diabetes. It would be preferable to define and use the term gestational diabetes or pregnancy-related diabetes much earlier. There is a quote from a researcher at Northwestern University who apparently is not affiliated with the latest findings. The story mentions treatment approaches of gestational diabetes, including diet, exercise, and insulin, which are appropriate. The article does not note the option of not treating (especially in the lower range) which is advocated by some. Assuming ""treatment"" in this case is ""exercise, a special diet, or insulin,"" the article does imply that these are available. Most, if not all, people will understand that treatment for high blood sugar is readily available. What’s new is that treatment of women with blood sugar that is high, but not high enough for a diagnosis of diabetes, may benefit from treatment with exercise, diet, or insulin as well. A more important wrinkle in this particular study is that ""treatment"" is inferred by practice patterns used at Kaiser and no individual-level data is available to determine if the women in the group that would have been provided with counseling/intervention of gestational diabetes actually received that counsel or acted on it. Thus the ""treated group"" is actually those who met gestational diabetes criteria by National Diabetes Data Group criteria – thus they are really the treatment eligible group among whom some (likely large) group received some completely not specified treatment. Treatment for gestational diabetes is not new, although the story does not explicitly state this. What the story implies is that diagnosis and treatment of diabetes at lower blood sugar thresholds than those currently treated may have a benefit for children, although more studies are needed. Diagnosing and treating more pregnant women with high blood sugar who don’t necessarily meet the traditional diabetes diagnosis would be new and there is some discussion around this. Since the story used at least one independent perspective, it does not appear to have relied soley or largely on a news release."

Ex Output:
Diabetes care during pregnancy reduces risk of obese children


Ex Input:
Rather than outline specific recommendations, the 300-page document is meant to be a resource for state regulators as they begin the process in 2020 of drafting formal rules aimed at reducing methane emissions. Despite industry claims that companies have been able to reduce emissions while still setting production records, environmentalists have been pushing hard for more regulations at the state level to target methane leaks and the practice of venting and flaring. The report is the result of numerous meetings over the last four months by the Methane Advisory Panel, a group of more than two dozen experts knowledgeable about various parts of the oil and gas business. The panel included industry representatives, environmental lawyers and experts from Los Alamos National Laboratory, Colorado State University and the New Mexico Institute of Mining and Technology. The discussions centered on topics like compressor engines, storage tanks and pneumatic valves. New Mexico Environment Secretary James Kenney said the effort put into the report is unparalleled in its thoroughness. “This is exactly the baseline information we need to effectively tackle methane emissions in our state,” he said. The state will be accepting public comment on the report through Feb. 20. XTO Energy President Staale Gjervik said the company’s experience shows methane emissions can be mitigated in a cost-effective way but that full industry participation is important. XTO was among those represented on the panel. The report highlights various strategies to reduce emissions, such as switching to low- or no-bleed pneumatic controllers and increasing leak detection and monitoring equipment. The need for more infrastructure also was identified as a possible way to reduce venting and flaring — although the report stated flaring, or the burning off of excess natural gas during extraction, was a necessary part of the process. The state will host public meetings in the coming months to discuss the findings with community members across the state. Stronger regulations for methane emissions will be critical as the oil boom in New Mexico continues, said Hillary Hull of the Environmental Defense Fund, another member of the advisory panel. She said the state’s process in developing the analysis was been inclusive, representing countless hours of research and input from a diverse cross-section of stakeholders. “Next year will be the critical time for moving forward on enforceable, nationally-leading methane rules that protect our air, address the climate crisis and improve education funding for New Mexico families and future generations,” she said. Earlier this month, trade groups representing the oil and gas industries in New Mexico and Texas release an analysis that showed a decline in methane emissions in both states as production tripled. The research also showed that the amount of methane burned off or emitted per barrel of oil equivalent was reduced by 64 percent in the Permian Basin during the past seven years. Meanwhile, the report cited a 210% increase in oil production in the Permian since 2011. Ryan Flynn, executive director at the New Mexico Oil and Gas Association said Permian producers are leading the industry when it comes to environmental practices and emissions reductions. “As energy markets across the globe look to America for their energy needs, we are creating the solutions of the future to deliver cleaner, more reliable energy to people and communities in every corner of the planet,” he said in a statement.

Ex Output:
New Mexico releases methane emissions report.


Ex Input:
“While Bayer is constructively engaged in the mediation process, there is no comprehensive agreement at this time. There also is no certainty or timetable for a comprehensive resolution,” the company said in a statement in reference to the settlement talks. The fourth jury trial in the Roundup litigation was scheduled to begin in St. Louis on Friday morning, but never got underway as lawyers for the company and the cancer patients sat down to discuss a hold of the trial. The lawsuit would have marked the first multi-plaintiff trial over whether glyphosate, Roundup’s active ingredient, is carcinogenic, and the first trial outside of California. St. Louis is the hometown of Roundup-maker Monsanto, a unit Bayer acquired in a $63 billion deal in 2018. Three consecutive juries previously found the company liable for causing cancer with damages of tens of millions of dollars awarded to each plaintiff. Bayer is appealing those verdicts. Court-appointed mediator Ken Feinberg, who leads the settlement discussions, has put the number of Roundup cancer claimants at more than 75,000 while Bayer said the claims it has been served with in court were below 50,000. Bayer on Friday said it will continue the mediation process under Feinberg in good faith.

Ex Output:

Bayer Roundup cancer trial postponed to continue settlement talks.